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A b s t r a c t
Background: An increase in the number of cardiac implantable electronic device (CIED) implantations is associated with 
a higher frequency of electrotherapy complications.  
Aim: The aim of the study was to determine the risk factors for late electrotherapy complications and to evaluate the effective-
ness of transvenous lead extraction (TLE) and survival after TLE.
Methods: We analysed the clinical data of 225 patients with electrotherapy complications referred for TLE in a single centre 
in the years 2006 to 2015. Indications for TLE, risk factors for infectious complications, effectiveness of TLE, and survival after 
the procedure were assessed.
Results: In the study group, non-infectious indications for TLE predominated (78.2%). Analysis of risk for infectious compli-
cations demonstrated the important role of chronic renal failure (hazard ratio [HR] 1.842, p = 0.034) and a greater number 
of CIED-related procedures (HR 4.768, p < 0.001). High effectiveness of TLE and significantly higher long-term mortality of 
patients with infectious complications compared with the remainder (50% vs. 20%, p < 0.05) were documented.
Conclusions: The study demonstrated a high rate of patients with non-infectious complications referred for TLE and very high 
effectiveness of the procedure. The worse long-term survival of patients with infectious complications, as well as increased 
risk for such complications due to the greater number of prior procedures, should prompt the consideration of early referral 
for TLE in the case of lead dysfunctions. 
Key words: late complications of electrotherapy, local pocket infection, lead-related infective endocarditis, transvenous lead 
extraction
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INTRODUCTION
The rise in the number of cardiac implantable electronic 
device (CIED) implantations: pacemakers (PMs), implantable 
cardioverter-defibrillators (ICDs), and cardiac resynchronisa-
tion therapy (CRT) devices, resulting from broader indications 
for implantation and a change in patient profile, is associated 
with an increased incidence of complications of electrother-
apy [1–5]. Particularly important are the late complications, 
appearing a few, or even over a dozen years, after implanta-
tion, because it is difficult to predict the risk factors for their 
occurrence, as well as to establish a single mode of action. The 
most commonly used method of treatment of such complica-
tions is complete removal of the system, i.e. transvenous lead 
extraction (TLE). The Heart Rhythm Society (HRS) guidelines 
from 2009 [1] concerning indications for TLE, and their up-
dated version from 2017 [6], do not solve all the problems 
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related to this field, often recommending the individualisa-
tion of therapy, especially in patients without symptoms of 
infection. It is therefore necessary to conduct further studies 
to clarify the indications for TLE due to non-infectious causes 
and clearly define their place in electrotherapy.
METHODS
Retrospective analysis of the clinical data of 225 patients 
(36% women) hospitalised in the Regional Cardiology Centre 
in the years 2006 to 2015 due to complications associated 
with PM/ICD/CRT was conducted. All patients undewent TLE, 
and all the procedures were performed by an experienced 
operator in a single Reference Centre. TLE was performed 
using polypropylene Byrd dilators (Cook® Medical, Leech-
burg, PA, USA) or rarely with the use of mechanical catheters 
(Evolution, Cook; TighRail Spectranetix). In the TLE centre, 
catheters using laser energy or electrosurgical dissection 
sheaths were not used. In the study group, 176 (78.2%) 
patients with non-infectious indications for TLE were identi-
fied, and there were 49 (21.8%) patients with infectious 
complications. Non-infectious indications included various 
types of lead dysfunction: breaking of the lead, dislocations 
(loops of the leads), late dry perforations of the exit block 
type with disorders of pacing, sensing, and resistance (P/S/R), 
symptomatic venous obstructions as well as the need for 
elective replacement of Sprint Fidelis leads, and prophylactic 
extractions of abandoned, redundant leads. Infections related 
to the presence of PM/ICD/CRT were divided into pocket 
infection (PI), lead-related infective endocarditis (LRIE),  and 
PI coexisting with LRIE.
The phenomenon of intracardiac abrasion of a lead was 
defined as macroscopically visible damage of external insulation 
located only in its intracardiac part, usually in the first 15 to 
20 cm from the tip. The presence of abrasion was confirmed 
on microscopic examinations [7, 8] carried out by researchers 
from the TLE centre to which study patients were referred.
Concepts such as TLE, total and clinical success of the 
procedure, major and minor complications, local PI, and LRIE 
were defined according to the 2017 TLE HRS guidelines [6] 
and the 2015 European Society of Cardiology guidelines [9]. 
In particular groups and subgroups of patients, the 
potential clinical factors and procedural complications of 
electrotherapy were evaluated. On the basis of univariate 
and multivariate analyses, risk factors for infectious compli-
cations were identified. The effectiveness of procedures, the 
occurrence of major and minor complications, and long-term 
survival after TLE were also assessed.
Survival status and date of death were obtained from the 
Ministry of Internal Affairs until 2014. In the years 2014 and 
2015 these data were complemented by the National Health 
Fund. The survival observation was completed in all patients af-
ter TLE. The authors have an official permit to obtain these data.
The study was approved by the local Bioethics Committee 
(decision number 02/2012).
Statistical analysis
The examined data are presented for all patients and for sub-
groups of patients classified according to the type of detected 
infectious complications. Continuous variables are presented 
as mean ± standard deviation and were compared using Stu-
dent t test. Categorical data are presented as absolute numbers 
and percentages and were compared using the c2 test with 
Yates correction. If the p-value was less than 0.05, the odds 
ratio with 95% confidence interval was calculated. Calculation 
of Cox proportional hazards regression analysis (uni- and mul-
tivariate) was applied to identify the variables associated with 
infective system dysfunction and prognosis after TLE. Multi-
variate regression analysis included the data that obtained 
a p-value of < 0.1 in univariate analysis. Survival analysis 
based on Kaplan-Meier curves and log-rank tests was used to 
assess the death-free survival after TLE depending on the type 
of detected infectious complications. Differences between the 
groups were considered statistically significant at p < 0.05. 
If the p-value ranged between 0.05 and 0.1 (estimated to the 
third decimal place), the value of p ≥ 0.1 was determined as 
non-statistical. Statistical analysis was performed with 10.0 Sta-
tistica software (StatSoft Inc., Tulsa, OK, USA).
RESULTS
The study included 225 patients (36.9% patients with ICD, 
3.9% with CRT) in whom a total of 313 leads were removed. 
Among them, 176 (78.2%) patients were referred for TLE due 
to non-infectious indications, and 49 (21.8%) patients due to 
causes related to infection (Fig. 1A). In patients with infectious 
complications, the causes for referral for TLE were isolated PI 
in 16 (32.7%) patients, PI with LRIE in 23 (46.9%) patients, 
and isolated LRIE in 10 (20.4%) patients (Fig. 1B). 
Non-infective causes for qualification for TLE were 
divided into classes in accordance with the HRS guidelines 
[1, 3]. The presented classification distinguishes primary and 
lower-level indications. The most common type of indica-
tion for TLE was the removal of superfluous non-functional 
leads — it was present in 79.5% of patients and constituted 
a primary indication in 52.8% of cases. Another indication 
was the presence of leads that pose a potential threat to the 
patient, it was identified in 54.5% of patients and classified as 
a primary indication in 29.5% of them. Among the primary 
indications, an important one was the need for the removal 
of an excess of functional leads, demonstrated by 6.3% of 
patients. A very important indication of the lower-level was 
the need for the recapture of venous access, identified in 
15.9% of patients. Other types of indications included in-
terference with an active pacing system or with anti-cancer 
therapy, chronic pain at the site of device insertion, reces-
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sion of pacing indication, recalled leads, and missed tip 
location (Table 1).
Analysis of clinical factors potentially affecting the de-
velopment of electrotherapy complications showed a higher 
incidence of chronic renal failure (CRF) in patients with LRIE. 
Other clinical parameters were comparable between subjects 
in different groups and subgroups (Table 2). 
Comparison of factors related to implantable devices 
showed more frequent presence of abandoned, non-function-
al leads in patients with infectious complications (especially 
in patients with LRIE), including systems implanted on both 
sides of the chest, and a greater number of implanted leads 
in this group of patients. In patients referred for TLE due to 
infection, significantly more previous CIED-related procedures 
were also observed, with a clearly shorter time interval since 
the last procedure preceding TLE, and the largest number of 
early reinterventions in patients with PI. The study showed 
no significant difference between the type of the implanted 
system and the dwell time of the leads removed in infectious 
and non-infectious groups (Table 2). 
Major TLE complications were observed in one (0.4%) 
patient, and minor complications in three (1.3%) patients. In 
the studied population no periprocedural death occurred 
(Table 2).  
Assessment of the risk  
for infectious complications
Based on univariate analysis, a higher incidence of infectious 
complications in patients with CRF was observed, with a great-
er number of implanted leads (in particular non-functional, 
abandoned ones), older leads (with a higher sum of the lead 
dwell time), and more frequent history of prior CIED-related 
procedures, in particular performed in a shorter span of time 
before TLE (Table 3). 
Multivariate analysis confirmed the effect of CRF and 
a greater number of procedures preceding TLE on the devel-
opment of infectious complications (Table 4).
Among the parameters potentially affecting the develop-
ment of isolated pocket infection, based on univariate analysis, 
the importance of the number of leads and the number of 
procedures prior to TLE, especially early reinterventions, was 
highlighted (Table 5).
Analysis of factors potentially affecting the development 
of PI coexisting with LRIE revealed significant effects of CRF, 
the number of implanted leads, especially non-functional 
ones, and the number of prior procedures, especially those 
performed a short time before TLE (Table 6).
Among the factors potentially affecting the development 
of isolated LRIE, univariate analysis demonstrated the impor-
tance of the number of leads, especially abandoned ones, 
the impact of lead dwell time (the sum of dwell time of all 
the leads), and the number of procedures preceding TLE, in 
particular those performed a short time before TLE (Table 7).
Evaluation of the effectiveness  
and safety of TLE
Total procedural success was observed in 96.9% of patients 
undergoing TLE, and clinical success was observed in 99.6% of 
patients. In the whole population there was no periprocedural 
death. A major complication occurred in one patient — peri-
cardial tamponade controlled by drainage of the pericardium. 
Minor complications were observed in three (1.3%) patients 
and included significant tricuspid regurgitation associated 
with the rupture of the chordae tendineae during TLE (two 
Figure 1. Analysis of indications for transvenous leads extraction. A. Classification of complications throughout the entire studied 
group (n = 225); B. Type of infectious complications (n = 49); LRIE — lead-related infective endocarditis; PI — pocket infections 
A B
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patients) and air embolism (one patient). The effectiveness 
of treatment in patients with infectious and non-infectious 
complications was comparatively high (Table 1).
Analysis of survival after TLE 
Rating long-term survival after TLE (mean follow-up period 
of 3.0 ± 2.14 years in the whole studied group) showed 
significantly higher mortality among patients with infectious 
complications. During a five-year observation period, the 
mortality rate in this group was about 50%, compared with 
about 20% in the non-infectious group (p < 0.05; Fig. 2).
DISCUSSION
Complications of electrotherapy are a relatively new problem in 
modern cardiology, and so there are few studies on the methods 
of action in a variety of clinical situations, while therapeutic 
standards are based on the short duration of patient observa-
tion. In the present study, in the group of patients referred for 
TLE in the years 2006–2015, a very low percentage of infectious 
complications (21.9%) representing an absolute indication for 
TLE was demonstrated. This rate is highly variable depending 
on the centre and the study population. In most TLE centres 
the percentage of infectious indications is 40% to 60% [10–12], 
but it may even reach the level of 70% to 80% [13, 14]. In 
recent years, however, there have been studies showing sig-
nificantly more frequent referral for TLE due to non-infectious 
causes. Based on the analysis of data from the National Cardio-
vascular Data Registry from the period of 2010 to 2012, it was 
determined that the percentage of infectious indications in this 
population was only 15% [15]. The existence of such a large 
discrepancy may be due to steadily increasing awareness of 
the complications of electrotherapy, which may result in their 
frequent recognition at an early stage, leading to the prevention 
of the development of infectious complications. This concept 
has been confirmed in the current study; the important fac-
tors in the risk of infections associated with PM/ICD/CRT were 
the number of CIED-related procedures preceding TLE, and 
a greater number of implanted leads, especially superfluous 
and abandoned ones in patients with LRIE. Such results have 
been reported in studies based on large populations of patients 
undergoing TLE [16, 17].
Detailed analysis of non-infectious complications in the 
current population showed that the dominant indication for 
TLE was the presence of unnecessary, abandoned leads (52.8% 
of primary indications, 79.5% of all indications) and extraction 
of potentially threatening leads (29.5% and 54.5%, respective-
ly). This type of indication is most often identified as class IIb 
in the HRS guidelines [6]. In clinical practice this means special 
consideration of the risk-benefit balance of the procedure. 
The spectrum of non-infective indications, especially the 
percentage of extraction of functional and non-functional 
leads, illustrates how frequently our doctors consider lots of 
patients with long life perspectives with abandoned leads in 
terms of problems far in the future. 
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Table 4. Multivariate analysis of the risk of infectious complications in patients with implanted pacemaker/ICD/CRT
All study patients (n = 225) HR 95% CI p
Creatinine level 1.842 1.049–3.248 0.034
Sum of lead dwell time 0.961 0.909–1.016 0.162
Number of previous procedures 4.768 2.253–10.093 0.000
Presence of abandoned leads 1.111 0.039–31.881 0.951
Number of abandoned leads in a patient 1.135 0.094–13.753 0.920
Early reintervention (within two months before TLE) 3.270 0.687–15.558 0.134
Abbreviations — see Tables 2 and 3
Table 3. Univariate analysis of the risk of infectious complications in the studied population
All study patients (n = 225) HR 95% CI p
Male sex 1.537 0.767–3.077 0.223
Age during implantation 0.998 0.972–1.024 0.865
Age during TLE 1.004 0.977–1.031 0.796
LVEF 1.057 0.786–1.421 0.714
NYHA class 1.067 0.680–1.675 0.777
Diabetes mellitus 1.166 0.540–2.520 0.694
Creatinine level 1.570 0.934–2.640 0.087
Atrial fibrillation 1.211 0.603–2.431 0.589
Anticoagulation therapy 0.735 0.367–1.476 0.385
Antiplatelet therapy 1.173 0.619–2.222 0.623
Number of leads 1.462 0.888–2.408 0.133
Number of active leads 0.972 0.538–1.755 0.923
Presence of abandoned leads 3.621 1.309–10.014 0.013
Number of abandoned leads in a patient 2.621 1.231–5.581 0.012
Number of extracted leads in a patient 3.667 2.078–6.472 0.000
ICD lead 0.732 0.377–1.422 0.355
CS lead 0.429 0.051–3.610 0.433
CRT-D system 0.503 0.060–4.238 0.525
Intracardiac lead abrasion 0.686 0.247–1.909 0.468
Dwell time of oldest lead 1.043 0.974–1.118 0.226
Mean lead dwell time 1.020 0.945–1.102 0.606
Sum of lead dwell time 1.039 1.004–1.075 0.029
Number of procedures before TLE 3.436 2.115–5.583 0.000
Time from the latest procedure before TLE 0.970 0.956–0.984 0.000
Early reintervention (within two months before TLE) 5.700 1.712–18.977 0.004
Previous system upgrading 1.029 0.317–3.332 0.962
Upgrading with lead abandonment 2.230 0.510–9.758 0.284
Loop of leads irritating tricuspid valve 0.790 0.163–3.813 0.768
HR — hazard ratio; CI — confidence interval; other abbreviations — see Table 2
Table 5. Univariate analysis of the risk of isolated pocket infection (presentation only of significant factors)
Isolated pocket infection (n = 16) HR 95% CI p
Number of leads in a patient 2.621 1.235–5.563 0.012
Sum of lead dwell time 1.039 0.992–1.089 0.105
Number of previous procedures before TLE 4.070 2.176–7.609 0.000
Early reintervention (within two months before TLE) 11.400 2.678–48.522 0.001
Abbreviations — see Tables 2 and 3
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Table 6. Univariate analysis of the risk of local pocket infection with coexisting lead-related infective endocarditis (PI + LRIE) — 
presentation only of significant factors
PI + LRIE (n = 23) HR 95%  p
Creatinine level 1.795 1.007–3.200 0.046
Presence of abandoned leads 4.123 1.350–12.595 0.012
Number of abandoned leads in a patient 2.823 1.22–6.492 0.014
Number of extracted leads in a patient 3.745 1.980–7.084 0.000
Sum of lead dwell time 1.033 0.995–1.073 0.087
Number of procedures before TLE 2.840 1.675–4.814 0.000
Time from the latest procedure before TLE 0.967 0.950–0.984 0.000
Abbreviations — see Tables 2 and 3
Table 7. Univariate analysis of the risk of isolated lead-related infective endocarditis (LRIE) — presentation only of significant 
factors
Isolated LRIE (n = 10) HR 95%  p
Presence of abandoned leads 3.621 1.309–10.014 0.013
Number of abandoned leads in a patient 2.621 1.231–5.581 0.012
Number of extracted leads in a patient 2.652 1.091–6.448 0.031
Sum of lead dwell time 1.039 1.004–1.075 0.029
Number of procedures before TLE 3.436 2.115–5.583 0.000
Time from the latest procedure before TLE 0.970 0.956–0.984 0.000
Early reintervention (within two months before TLE) 5.700 1.712–18.977 0.004
Abbreviations — see Tables 2 and 3
Figure 2. Kaplan-Meier survival curves of patients with 
complications of electrotherapy. Survival in the whole group 
of patients after transvenous lead extraction depending on 
aetiology: p < 0.05
The present study confirmed the high effectiveness and 
safety of TLE. According to reports evaluating TLE procedures 
in various populations, the overall procedural success ranged 
from 91%, in cases where the application of laser energy 
predominated [18] to 96%–98% in centres that preferred 
Byrd dilators and mechanical catheters [12, 19, 20]. The rate 
of major complications in these studies ranged from 0.3% to 
3.4% and was higher when laser techniques were used [12, 
18–20]. As stated in the present study, an overall procedural 
success rate of 96.9%, a clinical success rate of 99.6% with 
a major complication rate of 0.4%, and the absence of 
periprocedural deaths support the very high effectiveness and 
safety of TLE procedures in a population with predominantly 
non-infectious indications. 
The present study also confirmed, similarly to other 
studies, a relatively high (30%–50%) long-term mortality in 
the population of patients undergoing TLE. The factors most 
frequently identified as increasing mortality in long-term 
follow-up are age, diabetes, renal insufficiency, and infec-
tious complications [13, 21–23]. In most reports, beneficial 
direct effects of TLE procedures are emphasised, especially in 
patients referred for the procedure due to infection, although 
the long-term survival of this population is low [24, 25]. The 
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present study confirmed a significantly higher five-year mor-
tality among patients with infectious complications. This ob-
servation may also result from the more unfavourable clinical 
profile of this group, not only from the presence of infection.
The main limitation of the study is the small study popu-
lation, the lack of a thorough follow-up of patients after TLE 
procedures, and especially the lack of data on the direct cause 
of death in the long-term follow-up and its relationship to 
infectious complications. 
In conclusion, a 10-year analysis of long-term com-
plications associated with the presence of PM/ICD/CRT 
showed that thorough diagnosis and effective treatment of 
non-infectious adverse events may prevent the development 
of the most dangerous infectious complications. In the present 
study, confirmed high effectiveness and safety of procedures 
performed in an experienced centre should prompt an early, 
preventive referral for TLE. Such action is very important in 
light of the high long-term mortality among patients with 
infectious complications.
Conflict of interest: none declared
References
1. Wilkoff BL, Love CJ, Byrd CL, et al. Transvenous lead extraction: 
Heart Rhythm Society expert consensus on facilities, training, in-
dications, and patient management: this document was endorsed 
by the American Heart Association (AHA). Heart Rhythm. 2009; 
6(7): 1085–1104, doi: 10.1016/j.hrthm.2009.05.020, indexed in 
Pubmed: 19560098.
2. Greenspon AJ, Patel JD, Lau E, et al. 16-year trends in the infection 
burden for pacemakers and implantable cardioverter-defibrilla-
tors in the United States 1993 to 2008. J Am Coll Cardiol. 2011; 
58(10): 1001–1006, doi: 10.1016/j.jacc.2011.04.033, indexed in 
Pubmed: 21867833.
3. Mańkowska-Załuska B, Chudzik M, Łobodziński S, et al. Param-
eters associated with one-year mortality and in-hospital adverse 
events in patients after emergency pacemaker implantation. 
Kardiol Pol. 2016; 74(5): 454–460, doi: 10.5603/KP.a2015.0211, 
indexed in Pubmed: 26502943.
4. Sterliński M, Przybylski A, Gepner K, et al. Over 10 years with 
an implantable cardioverter-defibrillator — a long term follow-up 
of 60 patients. Kardiol Pol. 2010; 68: 1023–1029.
5. Kempa M, Sławiński G, Lewicka E, et al. [Risk factors for 
cardiac device-related infection during two-year follow-up: 
a retrospective analysis]. Kardiol Pol. 2018; 76(4): 800–801, 
doi: 10.5603/KP.2018.0079, indexed in Pubmed: 29652425.
6. Kusumoto FM, Schoenfeld MH, Wilkoff BL, et al. 2017 HRS 
expert consensus statement on cardiovascular implantable elec-
tronic device lead management and extraction. Heart Rhythm. 
2017; 14(12): e503–e551, doi:  10.1016/j.hrthm.2017.09.001, 
indexed in Pubmed: 28919379.
7. Kolodzinska K, Kutarski A, Grabowski M, et al. Abrasions of the 
outer silicone insulation of endocardial leads in their intracardiac 
part: a new mechanism of lead-dependent endocarditis. Eu-
ropace. 2012; 14(6): 903–910, doi:  10.1093/europace/eus003, 
indexed in Pubmed: 22310151.
8. Kutarski A, Małecka B, Kołodzinska A, et al. Mutual abrasion of 
endocardial leads: analysis of explanted leads. Pacing Clin Elec-
trophysiol. 2013; 36(12): 1503–1511, doi: 10.1111/pace.12216, 
indexed in Pubmed: 23919508.
9. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines 
for the management of infective endocarditis: The Task Force 
for the Management of Infective Endocarditis of the European 
Society of Cardiology (ESC). Endorsed by: European Asso-
ciation for Cardio-Thoracic Surgery (EACTS), the European 
Association of Nuclear Medicine (EANM). Eur Heart J. 2015; 
36(44): 3075–3128, doi: 10.1093/eurheartj/ehv319, indexed in 
Pubmed: 26320109.
10. Wazni O, Epstein LM, Carrillo RG, et al. Lead extraction in the 
contemporary setting: the LExICon study: an observational ret-
rospective study of consecutive laser lead extractions. J Am Coll 
Cardiol. 2010; 55(6): 579–586, doi: 10.1016/j.jacc.2009.08.070, 
indexed in Pubmed: 20152562.
11. Brunner MP, Cronin EM, Duarte VE, et al. Clinical predictors 
of adverse patient outcomes in an experience of more than 
5000 chronic endovascular pacemaker and defibrillator lead 
extractions. Heart Rhythm. 2014; 11(5): 799–805, doi: 10.1016/j.
hrthm.2014.01.016, indexed in Pubmed: 24444444.
12. Bongiorni MG, Kennergren C, Butter C, et al. The European 
Lead Extraction ConTRolled (ELECTRa) study: a European 
Heart Rhythm Association (EHRA) Registry of Transvenous 
Lead Extraction Outcomes. Eur Heart J. 2017; 38(40): 2995–3005, 
doi: 10.1093/eurheartj/ehx080, indexed in Pubmed: 28369414.
13. Gomes S, Cranney G, Bennett M, et al. Long-Term Outcomes 
Following Transvenous Lead Extraction. Pacing Clin Electro-
physiol. 2016; 39(4): 345–351, doi: 10.1111/pace.12812, indexed 
in Pubmed: 26768807.
14. Agarwal SK, Kamireddy S, Nemec J, et al. Predictors of complica-
tions of endovascular chronic lead extractions from pacemakers 
and defibrillators: a single-operator experience. J Cardiovasc 
Electrophysiol. 2009; 20(2): 171–175, doi: 10.1111/j.1540-8167.
2008.01283.x, indexed in Pubmed: 18775042.
15. Sood N, Martin DT, Lampert R, et al. Incidence and predictors 
of perioperative complications with transvenous lead extrac-
tions: real-world experience with national cardiovascular data 
registry. Circ Arrhythm Electrophysiol. 2018; 11(2): e004768, 
doi: 10.1161/CIRCEP.116.004768, indexed in Pubmed: 29453324.
16. Polewczyk A, Jacheć W, Janion M, et al. Lead-Dependent In-
fective Endocarditis: The Role of Factors Predisposing to Its 
Development in an Analysis of 414 Clinical Cases. Pacing Clin 
Electrophysiol. 2015; 38(7): 846–856, doi: 10.1111/pace.12615, 
indexed in Pubmed: 25683205.
17. Polewczyk A, Jacheć W, Polewczyk AM, et al. Infectious compli-
cations in patients with cardiac implantable electronic devices: 
risk factors, prevention, and prognosis. Pol Arch Intern Med. 
2017; 127(9): 597–607, doi: 10.20452/pamw.4065, indexed in 
Pubmed: 28724879.
18. Kennergren C, Bjurman C, Wiklund R, et al. A single-centre 
experience of over one thousand lead extractions. Europace. 
2009; 11(5): 612–617, doi: 10.1093/europace/eup054, indexed 
in Pubmed: 19329797.
19. Gomes S, Cranney G, Bennett M, et al. Twenty-year experience 
of transvenous lead extraction at a single centre. Europace. 
2014; 16(9): 1350–1355, doi: 10.1093/europace/eut424, indexed 
in Pubmed: 24554523.
20. Bongiorni MG, Soldati E, Zucchelli G, et al. Transvenous removal 
of pacing and implantable cardiac defibrillating leads using single 
sheath mechanical dilatation and multiple venous approaches: 
high success rate and safety in more than 2000 leads. Eur Heart J. 
2008; 29(23): 2886–2893, doi: 10.1093/eurheartj/ehn461, indexed 
in Pubmed: 18948356.
21. Maytin M, Jones SO, Epstein LM. Long-term mortality after 
transvenous lead extraction. Circ Arrhythm Electrophysiol. 
2012; 5(2): 252–257, doi: 10.1161/CIRCEP.111.965277, indexed 
in Pubmed: 22362891.
22. Polewczyk A, Jacheć W, Tomaszewski A, et al. Lead-related infec-
tive endocarditis: Factors influencing early and long-term sur-
vival in patients undergoing transvenous lead extraction. Heart 
www.kardiologiapolska.pl
Szymon J. Domagała et al.
1358
Rhythm. 2017; 14(1): 43–49, doi: 10.1016/j.hrthm.2016.10.007, 
indexed in Pubmed: 27725287.
23. Le Dolley Y, Thuny F, Mancini J, et al. Diagnosis of cardiac 
device-related infective endocarditis after device removal. JACC 
Cardiovasc Imaging. 2010; 3(7): 673–681, doi:  10.1016/j.
jcmg.2009.12.016, indexed in Pubmed: 20633844.
24. Henrikson CA, Zhang K, Brinker JA. High mid-term mortality 
following successful lead extraction for infection. Pacing Clin 
Electrophysiol. 2011; 34(1): 32–36, doi: 10.1111/j.1540-8159.20
10.02941.x, indexed in Pubmed: 21039644.
25. Tarakji KG, Wazni OM, Harb S, et al. Risk factors for 1-year 
mortality among patients with cardiac implantable electronic 
device infection undergoing transvenous lead extraction: the 
impact of the infection type and the presence of vegetation on 
survival. Europace. 2014; 16(10): 1490–1495, doi: 10.1093/euro-
pace/euu147, indexed in Pubmed: 25087154.
WHAT IS NEW?
The current study presents a modern approach to the problem of complications observed in patients with cardiac implant-
able electronic devices. A thorough diagnosis of lead dysfunction and early referral for transvenous lead extraction may 
contribute to a reduction in infectious complications. In the present study, a very high effectiveness and safety of procedures 
performed by an experienced operator were demonstrated and there was a significantly higher survival rate of patients 
undergoing transvenous lead extraction due to non-infectious causes. Documenting the benefits of the procedure should 
bring measurable clinical effects in the form of a reduction in the number of the most dangerous infectious complications 
and improved survival of patients with electrotherapy complications.
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